Tosufloxacin
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282948This classification denotes a quinolone antibiotic with the molecular formula C19H15F3N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GHJ553KQPS, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo- but generally known as tosufloxacin, which bears US NIH Compound Identifier 5517. European Medicines Agency schedules Tosufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11201MIG. The term TOSUFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). TOSUFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tosufloxacin under HS 29339990 and SITC 51577. As of Q4 2014, TOSUFLOXACIN remains the US FDA Preferred Term for this commodity. Tosufloxacin bears US NLM identifiers UMLS ID C0076843 and NCI Concept Code C80642. SMILES: FC1C(N2CC(N)CC2)NC2N(CC(C(=O)C2C1)C(=O)O)C1C(F)CC(F)CC1.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.